Press release
Monoclonal Antibody Therapeutics Industry Growth Forecast To 2031 | Leading Companies - F. Hoffmann-La Roche, Novartis AG, Merck & Co. Inc., Pfizer Inc
Monoclonal Antibody Therapeutics Industry
Monoclonal Antibody Therapeutics Market Industry Outlook - Strategic Insights for 2025
Monoclonal Antibody Therapeutics Market is witnessing transformative growth in 2025, driven by evolving consumer demand, technology disruption, and sustainability trends. The newly released market research report by DataM Intelligence offers deep insights into segmentation, competitive landscape, and growth forecasts, helping marketers and decision-makers formulate high-impact strategies.
Get exclusive insights with our detailed sample report (Corporate Email ID to get priority access) @ https://datamintelligence.com/download-sample/monoclonal-antibody-therapeutics-market?kb
Monoclonal antibody therapeutics are lab-made molecules that mimic natural antibodies to treat diseases like cancer, autoimmune disorders, and infectious diseases by targeting specific antigens.
Leading Market players in the Monoclonal Antibody Therapeutics Market
The prominent players in Monoclonal Antibody Therapeutics market research report are:
F. Hoffmann-La Roche, Novartis AG, Merck & Co. Inc., Pfizer Inc., Eli Lilly and Co. (Lilly), Sanofi, AstraZeneca, Bayer AG, Regeneron Pharmaceuticals Inc., and GSK Plc among others.
These companies are primarily focusing on strategies such as new product launches to penetrate the fastest-growing emerging markets across the world.
Industry Development
In May 2023, the U.S. Food and Drug Administration (FDA) approved the Investigational New Drug (IND) application for ATG-031, a first-in-class anti-CD24 monoclonal antibody, enabling the initiation of its Phase I clinical trial. The drug is developed by Antengene Corporation Limited, a global, commercial-stage biopharmaceutical company committed to discovering, developing, and commercializing first-in-class therapies in oncology and hematology.
In April 2023, Prometheus Biosciences, Inc., a clinical-stage biotechnology company known for its precision medicine approach to treating immune-mediated diseases, announced a definitive agreement with Merck & Co., Inc. (known as MSD outside the U.S. and Canada). As per the agreement, Merck will acquire Prometheus for $3.3 billion, strengthening its portfolio in immunology and personalized therapies.
In February 2023, Pfizer announced that its investigational bispecific antibody, Elranatamab, which targets B-cell maturation antigen (BCMA) and CD3, received Priority Review status from the U.S. FDA. The Biologics License Application (BLA) submission supports its use in patients with relapsed or refractory multiple myeloma (RRMM).
Market Segments
By Product Type: Naked, Fusion Protein, Antibody fragment, Conjugate, Multi-specific
By Application: Cancer, Autoimmune Diseases, Infectious Diseases, Others
By Production Source: Human, Humanized, Chimeric, Others
By End User: Hospitals, Private Clinics, Research Institutes
Buy Now & Unlock 360° Market Intelligence: https://datamintelligence.com/buy-now-page?report=monoclonal-antibody-therapeutics-market?kb
Research Methodology:
The global Monoclonal Antibody Therapeutics Market research report employs a comprehensive dual-source approach, integrating both primary and secondary data collection methods to ensure robust market analysis. Our research framework systematically evaluates multiple industry-influencing variables, including regulatory frameworks and government policies, prevailing market conditions, competitive intensity levels, historical performance data, current market positioning, technological innovations and disruptions, emerging industry developments, cross-sector business impacts, market volatility patterns, growth prospects, potential market barriers, and strategic challenges facing industry participants.
Speak to Our Analyst and Get Customization in the report as per your requirements @ https://datamintelligence.com/customize/monoclonal-antibody-therapeutics-market?kb
Regions Covered:
The global Monoclonal Antibody Therapeutics Market report focuses on six major regions: North America, South America, Europe, Asia Pacific, the Middle East, and Africa.
☞ North America - US, Canada, Mexico
☞ Europe- Germany, Russia, UK, France, Italy, Rest of Europe
☞ Asia Pacific- China, India, Japan, Australia, Rest of Asia Pacific
☞ South America- Brazil, Argentina, Colombia, Rest of South America
☞ Middle East and Africa- Saudi Arabia, UAE, Oman, Bahrain, Qatar, Kuwait, Israel
Most Frequently Asked Questions in the Monoclonal Antibody Therapeutics Market Research Industry:
➠ Who leads the Monoclonal Antibody Therapeutics industry and what's their competitive positioning regarding capacity, performance, and profitability?
➠ What growth opportunities and market challenges do Monoclonal Antibody Therapeutics market vendors face?
➠ Which segments show the highest growth potential and market share distribution?
➠ What factors are driving or limiting Monoclonal Antibody Therapeutics market growth?
➠ What are the dominant sales and distribution strategies in the Monoclonal Antibody Therapeutics industry?
Purchase Your Subscription to Power Your Strategy with Precision: https://www.datamintelligence.com/reports-subscription?kb
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Monoclonal Antibody Therapeutics Industry Growth Forecast To 2031 | Leading Companies - F. Hoffmann-La Roche, Novartis AG, Merck & Co. Inc., Pfizer Inc here
News-ID: 4085735 • Views: …
More Releases from DataM Intelligence 4 Market Research LLP
Global RIM Market Analysis - Remote IT Services Growth, Challenges & Forecast To …
Global Remote Infrastructure Management Market reached US$ 38.9 billion in 2022 and is expected to reach US$ 83.5 billion by 2030, growing with a CAGR of 8.7% during the forecast period 2024-2031.
Remote Infrastructure Management Market Industry Outlook - Strategic Insights for 2025
Remote Infrastructure Management Market is witnessing transformative growth in 2025, driven by evolving consumer demand, technology disruption, and sustainability trends. The newly released market research report by DataM Intelligence…
Top Companies in Voltage Stabilizer Market Share, Trends & Global Growth Forecas …
Global Voltage Stabilizer Market reached US$ 20.8 billion in 2022 and is expected to reach US$ 34.4 billion by 2030, growing with a CAGR of 6.6% during the forecast period 2024-2031.
Voltage Stabilizer Market Industry Outlook - Strategic Insights for 2025
Voltage Stabilizer Market is witnessing transformative growth in 2025, driven by evolving consumer demand, technology disruption, and sustainability trends. The newly released market research report by DataM Intelligence offers deep insights…
Top Award Management Software Market in 2025 | Market Share & Future Outlook - B …
The Global Award Management Software Market reached US$ 0.6 billion in 2022 and is expected to reach US$ 1.1 billion by 2030, growing with a CAGR of 8.8% during the forecast period 2024-2031.
Award Management Software Market Industry Outlook - Strategic Insights for 2025
Award Management Software Market is witnessing transformative growth in 2025, driven by evolving consumer demand, technology disruption, and sustainability trends. The newly released market research report by DataM…
NdFeB Market Size, Share & Analysis 2025 | Neodymium Magnet, Rare-Earth Magnet I …
Global NdFeB (Neodymium Iron Boron) Magnets Market reached US$ 14.0 billion in 2022 and is expected to reach US$ 23.7 billion by 2031, growing with a CAGR of 6.9% during the forecast period 2024-2031.
NdFeB Magnets Market Industry Outlook - Strategic Insights for 2025
NdFeB Magnets Market is witnessing transformative growth in 2025, driven by evolving consumer demand, technology disruption, and sustainability trends. The newly released market research report by DataM Intelligence…
More Releases for Monoclonal
Impact COVID-19 on Monoclonal Antibodies Market 2021 Generated Opportunities for …
Different monoclonal antibodies with unique mechanism of actions have been approved over the past few years, which work on immune checkpoints such as CTLA-4, PD-1, and PD-L1. Manufacturers are focusing on developing drugs belonging to various classes in order to treat variety of diseases ranging from cancer to rare diseases. Monoclonal antibody coupled with chemotherapy agents is becoming a viable treatment option to treat various cancers. For instance, in 2017,…
Monoclonal Antibodies Market Outline and Updates..!!
Rising adoption of strategies such as acquisition, collaboration, and license agreement by the market players is expected to bolster the monoclonal antibodies market growth over the forecast period. For instance, in 2018, F. Hoffman-La Roche AG and Kymab Group Ltd entered into a clinical trial agreement to evaluate KY1044 (product of Kymab Group), a human monoclonal antibody, for the treatment of solid tumors. Also, in 2018, Novartis AG entered into…
Global Monoclonal Antibody Diagnostic Reagents Market
Antibodies are an essential tool for many applications including flow cytometric analysis, immunoprecipitation, enzyme-linked immunosorbent assay (ELISA), immunocytochemistry, western blotting, and immunohistochemistry. Moreover, monoclonal antibodies (MAbs) are significant diagnostic reagent used in microbiological research, biomedical research, and also in diagnosis of various diseases such as HIV, hepatitis, herpes simplex, influenza infections, chlamydia, as well as for the treatment of cancer. Therefore, due to its importance in the clinical application, it…
Monoclonal Antibody Custom Service Market Ravishing Growth with CAGR of 10.84% | …
Complete Study of Monoclonal Antibody Custom Service Market Research Report is added on MarketResearchFuture.com with Latest Advancement. Detail analysis on possible segments and sub segments of the market. Along with this regional analysis of the market which includes North America, Europe, Asia Pacific and Middle East and Africa.
Avail Premium Sample Copy @ https://www.marketresearchfuture.com/sample_request/4515
Monoclonal Antibody Custom Service Market – Overview
It is estimated that monoclonal antibody custom service market is expected to…
Global Monoclonal Antibodies Pipeline Analysis
The market for monoclonal antibodies (mAB) has become the fastest growing segment of the pharmaceutical industry. In 2012, there were more than 30 monoclonal antibody therapies approved by the FDA which generated annual sales of more than US$ 40 Billion. As the therapeutic mABs already play a significant part in effective medical treatment, it is most likely that their importance would increase by manyfolds in the future.
There has been a…
Global Cancer Monoclonal Antibodies Pipeline Analysis
In the past few years monoclonal antibodies have emerged as a therapeutic modality for cancer. These monoclonal antibodies are designed to selectively target cancer cells and extract various responses, thus indirectly protecting the non cancerous cells. This characteristic of monoclonal antibodies coupled with increasing potential of the oncology market has made many pharmaceutical giants to invest a significant portion of their R&D on cancer monoclonal antibodies.
In recent years the popularity…
